NCT04333303

Brief Summary

Advance Care Planning (ACP) is an approach to support individuals in understanding and sharing their values, treatment goals, and preferences regarding future medical care. This study aims to evaluate the clinical effectiveness of implementing a complex regional ACP program focussing on nursing homes and their related health care providers. For this purpose, a cluster-randomised controlled trial (cRCT) is being conducted in four study centres in Germany: Düsseldorf, Göttingen, Halle (Saale), and Munich. 44 nursing homes with 3,520 residents will be randomised into either an intervention group, receiving the ACP-intervention described below, or into a control group that will receive usual care. The complex ACP intervention comprises training of professional ACP facilitators (micro level), supporting organisational development in nursing homes and other relevant institutions (meso level), and moderating regional change management among a network of all related health care institutions and actors (macro level). Clinical outcomes will be measured in order to describe whether the intervention improved care consistency with care preferences. Data will be collected by two independent approaches: Firstly, participating nursing homes will provide anonymous data on all their long-term care residents of a defined time period, including the hospitalisation rate (primary outcome). The primary hypothesis will test whether the complex intervention reduces the rate of hospital admissions. A group comparison of all hospitalisations in the past 12 months is made 21 months after randomisation. Secondly, all residents who have given informed consent in the first three months of the study will be repeatedly surveyed until month 21 (or until they die earlier). Treatment decisions in the face of life-threatening illness that affect any of a list of pre-defined outcomes will be evaluated as to whether they were consistent with the residents' care preferences. If residents decease, patient-centered care in the last weeks of life will be evaluated by additional interviews with the next bereaved relative, and an involved nurse. Besides, bereaved relatives will be assessed for trauma, depression and anxiety. In addition, a process evaluation and a health economic evaluation are carried out according to Medical Research Council (MRC) recommendations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,927

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2020

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 31, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 3, 2020

Completed
3 days until next milestone

Study Start

First participant enrolled

April 6, 2020

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
Last Updated

August 15, 2023

Status Verified

August 1, 2023

Enrollment Period

2.4 years

First QC Date

March 31, 2020

Last Update Submit

August 11, 2023

Conditions

Keywords

Cluster Randomised Controlled Trial (cRCT)ACP Intervention

Outcome Measures

Primary Outcomes (1)

  • Change of hospital admissions

    Number of hospital admission per 100 residents

    21 months

Secondary Outcomes (8)

  • Change of hospital days

    21 months

  • Change in the number of residents whose preferences were (a) known and (b) followed in the face of potentially life-threatening events

    21 months

  • Change in the number of pre-specified unwanted invasive treatments

    21 months

  • Change in the rate of hospital as last place of care

    21 months

  • Change in the perception of concordance

    21 months

  • +3 more secondary outcomes

Study Arms (2)

Advance Care Planning Program

EXPERIMENTAL

Implementation of a complex regional Advance Care Planning program.

Other: Implementation of a complex regional Advance Care Planning program

Care as usual

NO INTERVENTION

Interventions

Sustainable implementation of ACP at micro- (qualification of professional ACP facilitators to lead conversations in cooperation with family physicians), meso- (qualification of relevant co-actors, organisational development of participating institutions) and macro-level (regional ACP steering group and network), ensuring that valid ACP is encouraged, facilitated, documented, known and honored. Core of the intervention is a modular 9-day-training for ACP facilitators. These will be preferably located in regional pools, serving more than one nursing home, and reimbursed, if certified, by German sickness funds based on recent legislation (§ 132g Social Code Book \[SGB\] V: 1 full-time facilitator for 400 residents). ACP conversations will be offered to all residents. Regional intervention at meso- and macro-level comprises various formats of specific ACP training and information for leadership and staff, and aims to support professional change management.

Advance Care Planning Program

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • all long-term care residents of the enrolled nursing homes

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Heinrich-Heine-University

Düsseldorf, Germany

Location

University Medical Center

Göttingen, Germany

Location

Martin Luther University

Halle, Germany

Location

University Hospital Großhadern, LMU

Munich, Germany

Location

Related Publications (2)

  • In der Schmitten J, Lex K, Mellert C, Rotharmel S, Wegscheider K, Marckmann G. Implementing an advance care planning program in German nursing homes: results of an inter-regionally controlled intervention trial. Dtsch Arztebl Int. 2014 Jan 24;111(4):50-7. doi: 10.3238/arztebl.2014.0050.

    PMID: 24612497BACKGROUND
  • Gotze K, Bausewein C, Feddersen B, Fuchs A, Hot A, Hummers E, Icks A, Kirchner A, Kleinert E, Klosterhalfen S, Kolbe H, Laag S, Langner H, Lezius S, Meyer G, Montalbo J, Nauck F, Reisinger C, Rieder N, Schildmann J, Schunk M, Stanze H, Vogel C, Wegscheider K, Zapf A, Marckmann G, In der Schmitten J; BEVOR study group. Effectiveness of a complex regional advance care planning intervention to improve care consistency with care preferences: study protocol for a multi-center, cluster-randomized controlled trial focusing on nursing home residents (BEVOR trial). Trials. 2022 Sep 12;23(1):770. doi: 10.1186/s13063-022-06576-3.

Study Officials

  • Eva Hummers, Professor

    Department of General Practice, University Medical Center Göttingen

    PRINCIPAL INVESTIGATOR
  • Friedemann Nauck, Professor

    Department of Palliative Medicine, University Medical Center Göttingen

    PRINCIPAL INVESTIGATOR
  • Gabriele Meyer, Professor

    Institute of Health and Nursing Science, Martin Luther University Halle-Wittenberg

    PRINCIPAL INVESTIGATOR
  • Jan Schildmann, Professor

    Institute of History and Ethics of Medicine, Martin Luther University Halle-Wittenberg

    PRINCIPAL INVESTIGATOR
  • Claudia Bausewein, Professor

    Department of Palliative Medicine, University Hospital Großhadern, LMU Munich

    PRINCIPAL INVESTIGATOR
  • Georg Marckmann, Professor

    Institute of Ethics, History and Theory of Medicine, LMU Munich

    PRINCIPAL INVESTIGATOR
  • Antonia Zapf, Professor

    Department of Medical Biometry and Epidemiology, UKE Hamburg

    PRINCIPAL INVESTIGATOR
  • Henrike Kolbe

    Coordination Center for Clinical Trials, Heinrich-Heine-University, Düsseldorf

    PRINCIPAL INVESTIGATOR
  • Andrea Icks, Professor

    Department of Public Health, Heinrich-Heine-University, Düsseldorf

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
1. Investigators will be blinded towards group allocation. There is as risk of unblinding of investigators, therefore we will determine true blinding status at follow-up. 2. Outcomes Assessors will be consequently blinded with regard to group assignment until the statistical analysis plan is finalized.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Of the anticipated 44 nursing homes entering randomisation, half (22) will be allocated to the ACP intervention, the others continue with usual care.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Jürgen in der Schmitten, MD, PhD, MPH

Study Record Dates

First Submitted

March 31, 2020

First Posted

April 3, 2020

Study Start

April 6, 2020

Primary Completion

August 31, 2022

Study Completion

January 31, 2023

Last Updated

August 15, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations